BRPI0813563B1 - Implante de tecido ósseo compreendendo íons de estrôncio - Google Patents
Implante de tecido ósseo compreendendo íons de estrôncio Download PDFInfo
- Publication number
- BRPI0813563B1 BRPI0813563B1 BRPI0813563-0A BRPI0813563A BRPI0813563B1 BR PI0813563 B1 BRPI0813563 B1 BR PI0813563B1 BR PI0813563 A BRPI0813563 A BR PI0813563A BR PI0813563 B1 BRPI0813563 B1 BR PI0813563B1
- Authority
- BR
- Brazil
- Prior art keywords
- implant
- strontium
- oxide layer
- ions
- bone
- Prior art date
Links
- 239000007943 implant Substances 0.000 title claims abstract description 295
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 98
- 229910001427 strontium ion Inorganic materials 0.000 title claims abstract description 71
- 238000000034 method Methods 0.000 claims abstract description 83
- 238000004519 manufacturing process Methods 0.000 claims abstract description 31
- 150000003839 salts Chemical class 0.000 claims abstract description 29
- 238000002513 implantation Methods 0.000 claims abstract description 22
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims description 61
- 229910052712 strontium Inorganic materials 0.000 claims description 58
- 239000010936 titanium Substances 0.000 claims description 35
- 150000002500 ions Chemical class 0.000 claims description 33
- 229910052719 titanium Inorganic materials 0.000 claims description 31
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 30
- UUCCCPNEFXQJEL-UHFFFAOYSA-L strontium dihydroxide Chemical compound [OH-].[OH-].[Sr+2] UUCCCPNEFXQJEL-UHFFFAOYSA-L 0.000 claims description 18
- 229910001866 strontium hydroxide Inorganic materials 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 17
- 239000011575 calcium Substances 0.000 claims description 16
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 15
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 15
- 239000011777 magnesium Substances 0.000 claims description 15
- 229910052791 calcium Inorganic materials 0.000 claims description 14
- 230000015572 biosynthetic process Effects 0.000 claims description 12
- 229910052749 magnesium Inorganic materials 0.000 claims description 12
- 229910044991 metal oxide Inorganic materials 0.000 claims description 11
- 150000004706 metal oxides Chemical group 0.000 claims description 11
- 238000001556 precipitation Methods 0.000 claims description 11
- 159000000008 strontium salts Chemical class 0.000 claims description 9
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 8
- 239000012670 alkaline solution Substances 0.000 claims description 8
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 7
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 6
- 239000002269 analeptic agent Substances 0.000 claims description 6
- 229910001424 calcium ion Inorganic materials 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 229910001069 Ti alloy Inorganic materials 0.000 claims description 5
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 5
- 239000001506 calcium phosphate Substances 0.000 claims description 5
- 235000011010 calcium phosphates Nutrition 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 5
- 229910052744 lithium Inorganic materials 0.000 claims description 5
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 4
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 4
- 229910001416 lithium ion Inorganic materials 0.000 claims description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- -1 calcium phosphate compound Chemical class 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 230000001376 precipitating effect Effects 0.000 claims description 2
- 230000011164 ossification Effects 0.000 abstract description 13
- 239000000843 powder Substances 0.000 abstract description 8
- 238000005422 blasting Methods 0.000 abstract description 5
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 45
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 21
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 16
- 108010035042 Osteoprotegerin Proteins 0.000 description 13
- 102000008108 Osteoprotegerin Human genes 0.000 description 13
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 13
- XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 description 13
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 12
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 239000000956 alloy Substances 0.000 description 10
- 229910045601 alloy Inorganic materials 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 9
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 9
- DHEQXMRUPNDRPG-UHFFFAOYSA-N strontium nitrate Chemical compound [Sr+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O DHEQXMRUPNDRPG-UHFFFAOYSA-N 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000007743 anodising Methods 0.000 description 8
- 229960002986 dinoprostone Drugs 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 238000010348 incorporation Methods 0.000 description 8
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 8
- 238000004113 cell culture Methods 0.000 description 7
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000003937 drug carrier Substances 0.000 description 6
- 230000035876 healing Effects 0.000 description 6
- 230000010354 integration Effects 0.000 description 6
- 238000011068 loading method Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 210000000963 osteoblast Anatomy 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- XXUZFRDUEGQHOV-UHFFFAOYSA-J strontium ranelate Chemical compound [Sr+2].[Sr+2].[O-]C(=O)CN(CC([O-])=O)C=1SC(C([O-])=O)=C(CC([O-])=O)C=1C#N XXUZFRDUEGQHOV-UHFFFAOYSA-J 0.000 description 6
- 230000003746 surface roughness Effects 0.000 description 6
- 230000000975 bioactive effect Effects 0.000 description 5
- 230000004663 cell proliferation Effects 0.000 description 5
- 229910052735 hafnium Inorganic materials 0.000 description 5
- 229910052758 niobium Inorganic materials 0.000 description 5
- 239000010955 niobium Substances 0.000 description 5
- 229940079488 strontium ranelate Drugs 0.000 description 5
- 229910052715 tantalum Inorganic materials 0.000 description 5
- 229910052726 zirconium Inorganic materials 0.000 description 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000002787 reinforcement Effects 0.000 description 4
- 238000004626 scanning electron microscopy Methods 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000004053 dental implant Substances 0.000 description 3
- 230000009881 electrostatic interaction Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000009616 inductively coupled plasma Methods 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000008092 positive effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000002303 tibia Anatomy 0.000 description 3
- 208000006386 Bone Resorption Diseases 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 101000798130 Homo sapiens Tumor necrosis factor receptor superfamily member 11B Proteins 0.000 description 2
- WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 description 2
- 229910001440 Mn2+ Inorganic materials 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 229910009973 Ti2O3 Inorganic materials 0.000 description 2
- 229910052586 apatite Inorganic materials 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 230000024279 bone resorption Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000004821 effect on bone Effects 0.000 description 2
- 238000009760 electrical discharge machining Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 102000052781 human TNFRSF11B Human genes 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 230000000278 osteoconductive effect Effects 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 238000011946 reduction process Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- IATRAKWUXMZMIY-UHFFFAOYSA-N strontium oxide Chemical compound [O-2].[Sr+2] IATRAKWUXMZMIY-UHFFFAOYSA-N 0.000 description 2
- UBXAKNTVXQMEAG-UHFFFAOYSA-L strontium sulfate Chemical compound [Sr+2].[O-]S([O-])(=O)=O UBXAKNTVXQMEAG-UHFFFAOYSA-L 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000007910 systemic administration Methods 0.000 description 2
- GQUJEMVIKWQAEH-UHFFFAOYSA-N titanium(III) oxide Chemical compound O=[Ti]O[Ti]=O GQUJEMVIKWQAEH-UHFFFAOYSA-N 0.000 description 2
- 238000004832 voltammetry Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 238000008940 Alkaline Phosphatase assay kit Methods 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 208000002354 Edentulous Jaw Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102100035650 Extracellular calcium-sensing receptor Human genes 0.000 description 1
- 101710159793 Extracellular calcium-sensing receptor Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241000906034 Orthops Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 229910000756 V alloy Inorganic materials 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- 239000002639 bone cement Substances 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 230000018678 bone mineralization Effects 0.000 description 1
- 230000010072 bone remodeling Effects 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- HBXWYZMULLEJSG-UHFFFAOYSA-N chromium vanadium Chemical compound [V][Cr][V][Cr] HBXWYZMULLEJSG-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010285 flame spraying Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910000449 hafnium oxide Inorganic materials 0.000 description 1
- WIHZLLGSGQNAGK-UHFFFAOYSA-N hafnium(4+);oxygen(2-) Chemical compound [O-2].[O-2].[Hf+4] WIHZLLGSGQNAGK-UHFFFAOYSA-N 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 238000011540 hip replacement Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- BDAGIHXWWSANSR-NJFSPNSNSA-N hydroxyformaldehyde Chemical compound O[14CH]=O BDAGIHXWWSANSR-NJFSPNSNSA-N 0.000 description 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910000484 niobium oxide Inorganic materials 0.000 description 1
- URLJKFSTXLNXLG-UHFFFAOYSA-N niobium(5+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Nb+5].[Nb+5] URLJKFSTXLNXLG-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
- 239000012285 osmium tetroxide Substances 0.000 description 1
- 238000010883 osseointegration Methods 0.000 description 1
- 230000001582 osteoblastic effect Effects 0.000 description 1
- 230000001599 osteoclastic effect Effects 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000007750 plasma spraying Methods 0.000 description 1
- 238000000623 plasma-assisted chemical vapour deposition Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011555 rabbit model Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 229910052702 rhenium Inorganic materials 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 229910052706 scandium Inorganic materials 0.000 description 1
- 238000001004 secondary ion mass spectrometry Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 239000002276 single tooth dental implant Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 206010041569 spinal fracture Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229910000018 strontium carbonate Inorganic materials 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- FVRNDBHWWSPNOM-UHFFFAOYSA-L strontium fluoride Chemical compound [F-].[F-].[Sr+2] FVRNDBHWWSPNOM-UHFFFAOYSA-L 0.000 description 1
- 229910001637 strontium fluoride Inorganic materials 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229910001936 tantalum oxide Inorganic materials 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/306—Other specific inorganic materials not covered by A61L27/303 - A61L27/32
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0003—Not used, see subgroups
- A61C8/0009—Consolidating prostheses or implants, e.g. by means of stabilising pins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/06—Titanium or titanium alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
- A61F2002/30677—Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00592—Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
- A61F2310/00598—Coating or prosthesis-covering structure made of compounds based on metal oxides or hydroxides
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Inorganic Chemistry (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Dentistry (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07112078A EP2014319A1 (en) | 2007-07-09 | 2007-07-09 | A bone tissue implant comprising strontium ions |
| EP07112078.6 | 2007-07-09 | ||
| PCT/EP2008/058859 WO2009007372A2 (en) | 2007-07-09 | 2008-07-08 | A bone tissue implant comprising strontium ions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0813563A2 BRPI0813563A2 (pt) | 2014-12-23 |
| BRPI0813563B1 true BRPI0813563B1 (pt) | 2022-06-07 |
Family
ID=38969811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0813563-0A BRPI0813563B1 (pt) | 2007-07-09 | 2008-07-08 | Implante de tecido ósseo compreendendo íons de estrôncio |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US9889227B2 (enExample) |
| EP (2) | EP2014319A1 (enExample) |
| JP (1) | JP5487102B2 (enExample) |
| KR (1) | KR20100057796A (enExample) |
| CN (1) | CN101687062B (enExample) |
| AU (1) | AU2008274302B2 (enExample) |
| BR (1) | BRPI0813563B1 (enExample) |
| CA (1) | CA2692388A1 (enExample) |
| WO (1) | WO2009007372A2 (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0902705D0 (en) * | 2009-02-19 | 2009-04-01 | Neoss Ltd | Surface treatment process for implant |
| US9629873B2 (en) | 2010-07-02 | 2017-04-25 | University Of Florida Research Foundation, Inc. | Bioresorbable metal alloy and implants made of same |
| US11491257B2 (en) | 2010-07-02 | 2022-11-08 | University Of Florida Research Foundation, Inc. | Bioresorbable metal alloy and implants |
| US20120195848A1 (en) * | 2011-01-27 | 2012-08-02 | The University Of Hong Kong | Strontium-containing bioactive bone cement |
| EP2522373A1 (en) * | 2011-05-11 | 2012-11-14 | Dentsply IH AB | Biocompatible component |
| WO2012175220A1 (en) * | 2011-06-24 | 2012-12-27 | Straumann Holding Ag | Body made of a ceramic material |
| KR101213355B1 (ko) * | 2011-12-27 | 2012-12-18 | 오스템임플란트 주식회사 | 초기 안정성이 증진된 치과용 임플란트 및 그 제조 방법 |
| CN102492974A (zh) * | 2011-12-30 | 2012-06-13 | 浙江大学 | 钛种植体表面制备可降解镁掺杂非晶态磷酸钙涂层的方法 |
| CA2880825C (en) * | 2012-03-20 | 2021-03-16 | Titan Spine, Llc | Friction-fit spinal endplate and endplate-preserving method |
| EP2641621A1 (en) | 2012-03-23 | 2013-09-25 | Elos Medtech Pinol A/S | Strontium based coating for body implants |
| WO2014027612A1 (ja) * | 2012-08-16 | 2014-02-20 | 学校法人中部大学 | 骨修復材料及びその製造方法 |
| EP2716261A1 (en) * | 2012-10-02 | 2014-04-09 | Titan Spine, LLC | Implants with self-deploying anchors |
| EP2716306A1 (en) * | 2012-10-05 | 2014-04-09 | Aarhus Universitet | Metal oxide functionalized by strontium |
| US10266922B2 (en) | 2013-07-03 | 2019-04-23 | University Of Florida Research Foundation Inc. | Biodegradable magnesium alloys, methods of manufacture thereof and articles comprising the same |
| WO2015069724A1 (en) | 2013-11-05 | 2015-05-14 | University Of Florida Research Foundation, Inc. | Articles comprising reversibly attached screws comprising a biodegradable composition, methods of manufacture thereof and uses thereof |
| US10687956B2 (en) | 2014-06-17 | 2020-06-23 | Titan Spine, Inc. | Corpectomy implants with roughened bioactive lateral surfaces |
| US10188770B2 (en) | 2014-06-26 | 2019-01-29 | Osstemimplant Co., Ltd. | Dental implant having enhanced early stability and method for manufacturing same |
| WO2016118444A1 (en) | 2015-01-23 | 2016-07-28 | University Of Florida Research Foundation, Inc. | Radiation shielding and mitigating alloys, methods of manufacture thereof and articles comprising the same |
| FR3034678A1 (fr) * | 2015-04-07 | 2016-10-14 | Geocorail | Dispositif, procede et compose pour la reconstruction osseuse d'un vertebre. |
| TWI726940B (zh) | 2015-11-20 | 2021-05-11 | 美商泰坦脊柱股份有限公司 | 積層製造整形外科植入物之方法 |
| US10821000B2 (en) | 2016-08-03 | 2020-11-03 | Titan Spine, Inc. | Titanium implant surfaces free from alpha case and with enhanced osteoinduction |
| CN106691609B (zh) * | 2016-11-24 | 2022-04-15 | 北京华钽生物科技开发有限公司 | 一种高亲组织耐腐蚀种植牙及其制造方法 |
| CN106492280B (zh) * | 2016-11-24 | 2022-03-01 | 北京华钽生物科技开发有限公司 | 一种抗感染、耐摩擦、生物相容性高人工关节制品及其制造方法 |
| WO2018174475A1 (ko) * | 2017-03-21 | 2018-09-27 | 조선대학교산학협력단 | 플라즈마 전해 산화 공정에서 금속과 실리콘이 함유된 전해질 조성물 및 그 조성물을 이용하여 금속이온과 실리콘 이온을 함유하는 수산화아파타이트가 코팅된 치과용 임플란트 제조방법 |
| CN111787928A (zh) * | 2017-07-31 | 2020-10-16 | 慧创骨科药品有限公司 | 提高骨密度的多矿物质补充剂 |
| CN108042846B (zh) * | 2018-01-15 | 2020-11-24 | 陕西科技大学 | 一种锶掺杂钽氧化物纳米棒结构生物活性涂层的制备方法 |
| CN110559477A (zh) * | 2018-11-01 | 2019-12-13 | 赵全明 | 一种医用钛合金表面含锰羟基磷灰石/二氧化钛生物陶瓷涂层及其制备方法 |
| CN110241453A (zh) * | 2019-04-25 | 2019-09-17 | 西南大学 | 一种缓释氟和铈的可降解锌合金骨钉及其制备方法 |
| CN110304939B (zh) * | 2019-07-15 | 2020-07-31 | 四川大学 | 用于牙槽骨缺损修复的掺锶磷酸钙陶瓷颗粒及其制备方法 |
| CN111467572B (zh) * | 2020-04-09 | 2022-07-29 | 上海交通大学医学院附属第九人民医院 | 一种种植体材料及其制备方法与应用 |
| CN111821506A (zh) * | 2020-06-16 | 2020-10-27 | 温州医科大学附属口腔医院 | 一种锶/银纳米涂层改性的骨仿生钛种植体的制备 |
| CN112545713A (zh) * | 2020-11-23 | 2021-03-26 | 天衍医疗器材有限公司 | 一种骨填充假体及其制备工艺 |
| CN112773931B (zh) * | 2021-01-04 | 2022-06-21 | 北京华钽生物科技开发有限公司 | 一种可吸收的增强骨植入物材料及其制备方法 |
| KR102585073B1 (ko) * | 2022-03-17 | 2023-10-06 | 구본준 | 플라즈마 용융 분사법을 이용한 임플란트 식립체의 표면 코팅 방법 |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1007601B (it) | 1973-02-10 | 1976-10-30 | Friedrichsfeld Gmbh | Endoprotesi ortopedica special mente articolare |
| CH568067A5 (enExample) | 1973-05-17 | 1975-10-31 | Friedrichsfeld Gmbh | |
| US3919723A (en) | 1974-05-20 | 1975-11-18 | Friedrichsfeld Gmbh | Bone shaft or bone joint prosthesis and process |
| DE2546824C2 (de) | 1975-10-18 | 1986-05-07 | Ernst Leitz Wetzlar Gmbh, 6330 Wetzlar | Beschichtete Endoprothese und Verfahren zu ihrer Herstellung |
| US4097935A (en) * | 1976-07-21 | 1978-07-04 | Sterling Drug Inc. | Hydroxylapatite ceramic |
| DE3433210C1 (de) | 1984-09-10 | 1986-06-05 | Hans Dr.med. Dr.med.dent. 8000 München Scheicher | Mittel zur Fuellung von Knochen- und Zahndefekten,zum Knochenaufbau,fuer Knochenkontaktschichten und fuer Knochen- und Zahnwurzelersatz und Verwendung von Carbonatapatit fuer diesen Zweck |
| US4737411A (en) | 1986-11-25 | 1988-04-12 | University Of Dayton | Controlled pore size ceramics particularly for orthopaedic and dental applications |
| JP3198125B2 (ja) | 1991-06-18 | 2001-08-13 | 株式会社アドバンス | インプラントの製造方法 |
| US5578314A (en) * | 1992-05-29 | 1996-11-26 | The Regents Of The University Of California | Multiple layer alginate coatings of biological tissue for transplantation |
| NO924697D0 (no) | 1992-12-04 | 1992-12-04 | Jan Erik Ellingsen | Kirurgisk implantat og en fremgangsmaate for behandling avkirurgisk implantat |
| US5372660A (en) | 1993-08-26 | 1994-12-13 | Smith & Nephew Richards, Inc. | Surface and near surface hardened medical implants |
| ATE337032T1 (de) | 1993-12-20 | 2006-09-15 | Astra Tech Ab | Verfahren zur behandlung eines implantates aus titan oder titanlegierung |
| US7048870B1 (en) | 1993-12-20 | 2006-05-23 | Astrazeneca Ab | Metallic implant and process for treating a metallic implant |
| US5705273A (en) | 1995-03-08 | 1998-01-06 | The Ohio State University | Method for strengthening dental restorative materials |
| SE513556C2 (sv) | 1997-11-11 | 2000-10-02 | Nobel Biocare Ab | Implantatelement med tunt ytskickt applicerat genom het isostatisk pressning |
| GB9808189D0 (en) | 1998-04-17 | 1998-06-17 | Royal Free Hosp School Med | Bone implant |
| US6261322B1 (en) | 1998-05-14 | 2001-07-17 | Hayes Medical, Inc. | Implant with composite coating |
| US6533969B1 (en) | 1998-06-12 | 2003-03-18 | Jeneric/Pentron, Inc. | Method of making high-strength dental restorations |
| EP1023910A1 (en) | 1999-01-29 | 2000-08-02 | Institut Straumann AG | Preparation of osteophilic surfaces for metallic prosthetic devices anchorable to bone |
| SE514323C2 (sv) | 1999-05-31 | 2001-02-12 | Nobel Biocare Ab | Implantat samt förfarande och användning vid implantat |
| US6593394B1 (en) | 2000-01-03 | 2003-07-15 | Prosperous Kingdom Limited | Bioactive and osteoporotic bone cement |
| US7048541B2 (en) | 2000-04-04 | 2006-05-23 | Nobel Biocare Ab | Implant having attachment and hole-insert parts, and method for producing such an implant |
| DK174876B1 (da) | 2001-02-26 | 2004-01-12 | Danfoss As | Implantat og implantatoverflademodificeringsproces |
| DK1381402T3 (da) | 2001-04-27 | 2010-03-08 | Vivoxid Oy | Fremgangsmåde til forbedring af blødvævsmodtagelse og implantater der gør brug af denne fremgangsmåde |
| US7291178B2 (en) * | 2001-05-29 | 2007-11-06 | Mediteam Dental Ab | Modified oxide |
| SE0101910D0 (sv) | 2001-05-29 | 2001-05-29 | Young Taeg Sul | Modified oxide |
| DE10128100A1 (de) | 2001-06-11 | 2002-12-19 | Hannover Med Hochschule | Medizinisches Implantat für den menschlichen und tierischen Körper |
| US6527938B2 (en) | 2001-06-21 | 2003-03-04 | Syntheon, Llc | Method for microporous surface modification of implantable metallic medical articles |
| GB0126467D0 (en) | 2001-11-03 | 2002-01-02 | Accentus Plc | Deposition of coatings on substrates |
| SE523236C2 (sv) | 2002-07-19 | 2004-04-06 | Astra Tech Ab | Ett implantat och ett förfarande för behandling av en implantatyta |
| SE523288C2 (sv) * | 2002-07-19 | 2004-04-06 | Astra Tech Ab | Ett implantat och ett förfarande för behandling av en implantatyta |
| US20040053197A1 (en) | 2002-09-16 | 2004-03-18 | Zoran Minevski | Biocompatible implants |
| DE10243132B4 (de) | 2002-09-17 | 2006-09-14 | Biocer Entwicklungs Gmbh | Antiinfektiöse, biokompatible Titanoxid-Beschichtungen für Implantate sowie Verfahren zu deren Herstellung |
| CN1313378C (zh) * | 2002-09-24 | 2007-05-02 | 北京化工大学 | 制备钛酸锶粉体的方法 |
| AU2004200704B2 (en) | 2003-02-24 | 2010-03-25 | Depuy Products, Inc. | Metallic implants having roughened surfaces and method for producing the same |
| EP1745791B1 (en) | 2003-05-07 | 2013-06-26 | Osteologix A/S | Treating cartilage/bone conditions with water-soluble strontium salts |
| US6905723B2 (en) | 2003-05-30 | 2005-06-14 | Depuy Products, Inc. | Strontium-substituted apatite coating |
| US7223079B2 (en) | 2003-07-28 | 2007-05-29 | The Coca-Cola Company | Quick loading peristaltic pump |
| JP4635177B2 (ja) * | 2003-09-02 | 2011-02-16 | 独立行政法人産業技術総合研究所 | 生体親和性インプラント材及びその製造方法 |
| DE10347347B4 (de) * | 2003-10-11 | 2006-02-16 | Daimlerchrysler Ag | Wählhebel und Verfahren zur Montage eines Wählhebels |
| AU2003279406A1 (en) | 2003-11-13 | 2004-06-06 | Lifenova Biomedical, S.A. | Method of producing endosseous implants or medical prostheses by means of ionic implantation, and endosseous implant or medical prosthesis thus produced |
| ATE482667T1 (de) | 2004-03-04 | 2010-10-15 | Young-Taek Sul | Osseoinduktives magnesium-titan-implantat und herstellungsverfahren dafür |
| KR100714244B1 (ko) * | 2004-04-26 | 2007-05-02 | 한국기계연구원 | 생체용 골유도성 금속 임플란트 및 그 제조방법 |
| CA2574115A1 (en) | 2004-07-21 | 2006-01-26 | The University Of British Columbia | Method of electrolytically depositing a pharmaceutical coating onto a conductive osteal implant |
| JP4403549B2 (ja) | 2004-09-15 | 2010-01-27 | 日本ビクター株式会社 | 動画像符号化装置及び動画像符号化用プログラム |
| US20060286136A1 (en) * | 2005-06-15 | 2006-12-21 | Cabot Microelectronics Corporation | Surface treatment of biomedical implant for improved biomedical performance |
| WO2008109016A1 (en) * | 2007-03-05 | 2008-09-12 | Signal Medical Corporation | Metal/alloy coated ceramic |
-
2007
- 2007-07-09 EP EP07112078A patent/EP2014319A1/en not_active Withdrawn
-
2008
- 2008-07-08 WO PCT/EP2008/058859 patent/WO2009007372A2/en not_active Ceased
- 2008-07-08 BR BRPI0813563-0A patent/BRPI0813563B1/pt active IP Right Grant
- 2008-07-08 CN CN200880024025.8A patent/CN101687062B/zh active Active
- 2008-07-08 KR KR1020107002822A patent/KR20100057796A/ko not_active Withdrawn
- 2008-07-08 AU AU2008274302A patent/AU2008274302B2/en active Active
- 2008-07-08 CA CA002692388A patent/CA2692388A1/en not_active Abandoned
- 2008-07-08 JP JP2010515495A patent/JP5487102B2/ja active Active
- 2008-07-08 US US12/299,010 patent/US9889227B2/en active Active
- 2008-07-08 EP EP08774896.8A patent/EP2187982B1/en active Active
-
2012
- 2012-08-21 US US13/591,147 patent/US9744263B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100057796A (ko) | 2010-06-01 |
| US9744263B2 (en) | 2017-08-29 |
| CN101687062B (zh) | 2014-04-02 |
| EP2014319A1 (en) | 2009-01-14 |
| EP2187982B1 (en) | 2019-04-24 |
| US9889227B2 (en) | 2018-02-13 |
| JP5487102B2 (ja) | 2014-05-07 |
| AU2008274302B2 (en) | 2011-12-01 |
| EP2187982A2 (en) | 2010-05-26 |
| BRPI0813563A2 (pt) | 2014-12-23 |
| CN101687062A (zh) | 2010-03-31 |
| WO2009007372A3 (en) | 2009-03-05 |
| WO2009007372A2 (en) | 2009-01-15 |
| US20120316570A1 (en) | 2012-12-13 |
| CA2692388A1 (en) | 2009-01-15 |
| AU2008274302A1 (en) | 2009-01-15 |
| JP2010533012A (ja) | 2010-10-21 |
| US20100174382A1 (en) | 2010-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0813563B1 (pt) | Implante de tecido ósseo compreendendo íons de estrôncio | |
| AU2008274301B2 (en) | A bone tissue implant comprising lithium ions | |
| Chen et al. | Bioactive NiTi shape memory alloy used as bone bonding implants | |
| Xue et al. | In vivo evaluation of plasma-sprayed titanium coating after alkali modification | |
| JP5658561B2 (ja) | ナノ表面 | |
| Bral et al. | In vivo biofunctionalization of titanium patient-specific implants with nano hydroxyapatite and other nano calcium phosphate coatings: A systematic review | |
| Fan et al. | Fabrication of TiO2 nanotubes on porous titanium scaffold and biocompatibility evaluation in vitro and in vivo | |
| Lee et al. | The cytocompatibility and osseointegration of the Ti implants with XPEED® surfaces | |
| Hägi et al. | Mechanical insertion properties of calcium‐phosphate implant coatings | |
| Badr et al. | Hydroxyapatite-Electroplated cp–Titanium Implant and Its Bone Integration Potentiality: An In Vivo Study | |
| Jassim et al. | The effect of implant screw coating with nano-hydroxyapatite and magnesium chloride mixture on osseointegration: Biomechanical and histological study | |
| RU2524764C1 (ru) | Способ получения дентального имплантата погружного типа из титана или титанового сплава и дентальный имплантат из титана или титанового сплава | |
| Toledo | Dental implant surface modifications and osteointegration | |
| Yang et al. | Calcium phosphate coating on AT titanium plate by CD and BD methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/07/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |